tirzepatide and sleep issues What clinicians should know about prescribing for apnea Studies Show Weight Loss Drug

Diabetes Care 47:13501359 Naaman SC, Bakris GL (2023) Diabetic nephropathy: update on pillars of therapy slowing progression

A 5% to 10% reduction in total body weight may enhance brain health, improve concentration, and accelerate brain processing

Renal Benefits Reduces the risk of renal diseases in type 2 diabetes patients

Of note is that the observed median time to onset of the psychiatric AEs in our analysis of the FAERS data aligned with common gastrointestinal AEs such as nausea and vomiting, which were the most frequently reported within the first 30 days of GLP-1 RA treatment ( In this extensive pharmacovigilance study, we observed a significant association between GLP-1 RAs and eight distinct categories of psychiatric AEs, namely, nervousness, stress, eating disorder, fear of injection, sleep disorder due to general medical conditioninsomnia type, binge eating, fear of eating, and self-induced vomiting